|
|
Volumn 192, Issue 4238, 1976, Pages 481-483
|
|
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZAPERONE;
BENPERIDOL;
BUTACLAMOL;
CHLORPROMAZINE;
CLOFLUPEROL;
CLOZAPINE;
DROPERIDOL;
DRUG RECEPTOR;
FLUANISONE;
FLUPENTIXOL;
FLUPHENAZINE;
FLUSPIRILENE;
HALOPERIDOL;
MOPERONE;
PENFLURIDOL;
PIMOZIDE;
PIPAMPERONE;
PROMAZINE;
PROMETHAZINE;
RADIOISOTOPE;
SPIPERONE;
THIORIDAZINE;
TIOTIXENE;
TRIFLUOPERAZINE;
TRIFLUPERIDOL;
BRAIN;
DOG;
DOPAMINE H 3;
DOPAMINERGIC NERVE CELL;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG COMPARISON;
DRUG INTERACTION;
DRUG RESPONSE;
HALOPERIDOL H 3;
RAT;
SCHIZOPHRENIA;
THEORETICAL STUDY;
ADENYLATE CYCLASE;
ANIMAL;
ANTIPSYCHOTIC AGENTS, PHENOTHIAZINE;
BINDING, COMPETITIVE;
BUTYROPHENONES;
CORPUS STRIATUM;
DOPAMINE;
DOPAMINE ANTAGONISTS;
HALOPERIDOL;
HUMAN;
OLFACTORY BULB;
RECEPTORS, DRUG;
SCHIZOPHRENIA;
STRUCTURE-ACTIVITY RELATIONSHIP;
SUPPORT, U.S. GOV'T, NON-P.H.S.;
SUPPORT, U.S. GOV'T, P.H.S.;
|
|
EID: 0017255979
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.3854 Document Type: Article |
|
Times cited : (1810)
|
|
References (0)
|
